Company Profile

Ariadne Genomics Inc
Profile last edited on: 6/17/13      CAGE: 47MJ7      UEI: ENKJNWT6CLZ6

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2003
Latest Award
2007
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9430 Key West Avenue Suite 113
Rockville, MD 20850
   (240) 453-6296
   info@ariadnegenomics.com
   www.ariadnegenomics.com
Location: Multiple
Congr. District: 08
County: Montgomery

Public Profile

In December 2011, Ariadne Genomics was acquired by Elsevier, provider of scientific, technical, and medical information products and services. Asiadne Genomics develops research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine. Thefirm provides a portfolio of solutions for life science, drug discovery and development applications including custom data products, knowledge extraction and visualization software, knowledge reports, and informatics staffing. Pathway Studio, built and powered by MedScan® technology, is integrated data mining and visualization software that allows organizations and researchers to rapidly extract relevant facts and relationships from large document collections (text-mining), visualize these facts in a biological context, and integrate and interpret OMICS experimental data. The extracted knowledge is used for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modeling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 1 NIH $100,000
Project Title: A Toxicological Knowledge Base Prototype
2005 2 NIH $838,313
Project Title: Flexible NLP system for MEDLINE information extraction

Key People / Management

  Ilya Mazo -- President

  Nikolai D Daraselia

Company News

There are no news available.